Mr. Chair, in response to the member's question and back to the point about who's responsible, the Public Health Agency does a surveillance. That surveillance is shared with Health Products and Food Branch, and the veterinary directorate considers that information and factors it into the risk assessment of all drugs. We put appropriate conditions on the label for the use of that drug. While there are numerous players, they collaborate quite closely and share information. When public health information has signals, that is shared with us as the regulator and that is factored into the regulatory decision we make.
With respect to the drug in question, we should clarify that the label is not tiny, such as a prescription label. It's quite extensive. We feel that the drug, when used as indicated on the label, is appropriate. It should not be used outside that label for extra label use. We have specific warnings on that. The label clearly indicates which species of livestock the drug can and should be used for and which indication. This should be used on a treatment basis, not on a preventive basis, and the types of species are clearly indicated on the label. Consistent with our assessment, if the operators follow those conditions, the drug can be used very safely.